Mymetics strengthens virosome vaccine platform

Epalinges, Switzerland, March 10, 2014

Mymetics announced today that it has secured andĀ further strengthened its know-how and leadership in the research and development of virosomeĀ based vaccines as well in manufacturing and IP.

Media Name Media Type Description Download
140310 Mymetics Press release virosome know-how and IP_final PDF Download